Worthington Mark - Insider Non-Derivative Transactions at Athira Pharma, Inc. (ATHA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 5, 2024, Worthington Mark's relationship to Athira Pharma, Inc. (ATHA) is Officer (GENERAL COUNSEL), and currently has 51,927 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ATHA insiders.
Data Source: SEC.
Worthington Mark - Insider Non-Derivative Transactions of ATHA Common Stock
Worthington Mark - Insider Non-Derivative Transactions at ATHA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 6, 2024 | Sell -- (Common Stock) | 2525 | 0.57 | 51927 |
| Sep 4, 2024 | Acquisition -- (Common Stock) | 10000 | 0 | 54452 |
| May 21, 2024 | Acquisition -- (Common Stock) | 10000 | 1.34 | 44452 |
| Jan 6, 2024 | Sell -- (Common Stock) | 2412 | 2.91 | 34452 |
| Jan 5, 2024 | Acquisition -- (Common Stock) | 10000 | 0 | 36864 |
| May 19, 2023 | Acquisition -- (Common Stock) | 7767 | 2.41 | 26864 |